Hepatitis C virus (HCV) infection is one of the commonest causes of liver c
irrhosis and hepatocellular carcinoma. This review deals with treatment of
chronic HCV infection with a combination of interferon and ribavirin. Recen
t trials have shown that approximately 40% of patients will clear HCV with
combination treatment. This is an important advance in the treatment of thi
s serious viral infection.